Polish oil refiner PKN Orlen is ready to offer concessions on its plan to buy rival Lotos once EU competition regulators set out their concerns about the deal in the coming days, Reuters reported.
State-run PKN, which wants to buy at least 53% of Lotos, is likely to get a statement of objections from the European Commission as early as this week, the sources said.
The EU competition enforcer typically uses the statement of objections to list specific areas where mergers could result in higher prices or put pressure on rivals, which can spur the company making the takeover bid to offer concessions.
The Commission opened a full-scale investigation into the deal in August last year, saying the deal might lead to higher prices and restrict competition.
The Commission declined to comment while PKN was not immediately available for comment. PKN Chief Executive Daniel Obajtek told a video conference that the Lotos deal was on track.
“It is necessary in this tough time. For the Polish economy and for the European one it is the only direction,” he said and urged the EU competition watchdog to liberalise its approach to mergers that strengthen the economy.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Mehta Questions Both Sides in Landmark Google Antitrust Case
May 2, 2024 by
CPI
FCC Urges Urgent Funding for Removal of Chinese Telecom Equipment from U.S. Networks
May 2, 2024 by
CPI
Former Pioneer CEO Facing Potential Criminal Charges For Colluding With OPEC
May 2, 2024 by
CPI
South Korea’s Antitrust Regulator Greenlights K-Pop Powerhouse Deal
May 2, 2024 by
CPI
Exxon’s Pioneer Purchase Approved, Former CEO Barred from Board
May 2, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI